Amphipathic Properties of HIV-1 Gp41 Fusion Inhibitors

Current Topics in Medicinal Chemistry - United Arab Emirates
doi 10.2174/156802611798808488
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Design of Potent Inhibitors of HIV-1 Entry From the Gp41 N-Peptide Region

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Mutations That Increase the Stability of the Post-Fusion Gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by Both an X4 and R5 HIV-1 Virus to Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of Gp41, but the Gp120 Adaptive Mutations Differ Between the Two Viruses

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

Peptides and Peptidomimetics as Tools to Probe Protein-Protein Interactions – Disruption of HIV-1 Gp41 Fusion Core and Fusion Inhibitor Design

2012English

HIV-1 Adapts to a Retrocyclin With Cationic Amino Acid Substitutions That Reduce Fusion Efficiency of Gp41

Journal of Immunology
AllergyImmunology
2006English

HIV Gp41 Fusion Peptide Increases Membrane Ordering in a Cholesterol-Dependent Fashion

Biophysical Journal
Biophysics
2014English

The Mechanism of Inhibition of HIV-1 Env-Mediated Cell–Cell Fusion by Recombinant Cores of Gp41 Ectodomain

Virology
Virology
2002English

Striking HIV-1 Entry by Targeting HIV-1 Gp41. But, Where Should We Target?

PLoS ONE
Multidisciplinary
2016English

Development of Indole Compounds as Small Molecule Fusion Inhibitors Targeting HIV-1 Glycoprotein-41

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2011English

The Conserved Residue Arg46 in the N-Terminal Heptad Repeat Domain of HIV-1 Gp41 Is Critical for Viral Fusion and Entry

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy